SeaStar Medical (ICU) announced that Michael Messinger has joined SeaStar Medical as CFO. He currently serves as a member of the board of directors of Filament Health Corp. (FLHLF) and a strategic consultant to various biotechnology companies.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICU:
- SeaStar Medical Reports Q3 2025 Financial Progress
- ICU Upcoming Earnings Report: What to Expect?
- Seastar Medical’s QUELIMMUNE Study: A Potential Game Changer for Pediatric AKI Treatment
- Seastar Medical’s Pivotal Study on Acute Kidney Injury: A Potential Game-Changer?
- Seastar Medical’s Innovative Approach to Treating Severe Heart Failure: A Study Update